HIV Diagnostics Market is predicted to rise from US$ 3.0 Billion in 2022

As per Future Market Insights, the HIV diagnostics market is predicted to rise from US$ 3.0 Bn in 2022 to US$ 6.4 Bn in 2032. The HIV diagnostics market is anticipated to record a steady CAGR of 7.9% during the period 2022-2032.

Technological improvements and increasing prevalence of HIV in developing and underdeveloped countries will foster the industry growth. HIV is one of the serious public health challenges across the globe. HIV if not treated on time can lead to formation of AIDS.

Despite numerous research and advances in scientific studies related to HIV still there is no vaccine and preventive medication to control the spread of the infection. One of the only methods to tackle the infectious is by treating it on time and access to proper treatment and care.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14678

Therefore, many governments, NGO’s and other organizations play a crucial role in creating proper awareness for the prevention of HIV/AIDS. Governments across the globe are undertaking numerous initiatives to educate its citizens regarding prevention and safer sex practices. They are developing better healthcare infrastructure to provide sophisticated patient care as well as management.

“Favourable regulatory environment and substantial investment in R&D activities by market participants for the development of improved quality HIV testing kits for home use is likely to propel the HIV diagnostics market growth.”

The demand for HIV diagnostics is forecasted to grow due to factors such as the rising global prevalence of HIV/AIDS, as well as the rising number of blood transfusions and blood donations.

What is the Segmentation Outlook for the HIV Diagnostics Market?

The consumable sector accounted for the largest market share in the global HIV diagnosis market. Consumption of consumables such as assays, reagents, and kits are on the rise, which is propelling the HIV diagnostics market forward.

HIV Diagnostics Market Key Players

  • Siemens Healthineers
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Danaher Corporation
  • Thermo-Fisher Scientific Inc

Report Customization available @ https://www.futuremarketinsights.com/customization-available/rep-gb-14678

HIV Diagnostics Market Key Segments

By Product:

  • Consumables
  • Instruments
  • Software & Services

By Test Type:

  • Antibody Tests
  • Viral Load Tests
  • CD4 Tests
  • Others

By End User:

  • Diagnostic Laboratories
  • Hospitals
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Ask an Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-14678

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on HIV Diagnostics

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background

    4.1. HIV Diagnostics Market, by Key Countries

    4.2. HIV Diagnostics Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Pressotherapy Systems Market Insights, Forecast by Regions & Countries, Top Company Profiles, Business Strategies

Pressotherapy Systems Market Overview:

Pressotherapy is a method related to lymphatic waste and cellulite. It is a new idea yet its appearing to have many advantages, in the evacuation of fat as well as in more different treatment ranges, for example, tattoo removal. It offers the customer solutions for lymph seepage, lessening of cellulite, expanded fat digestion and developed for efficient removal of the tattoo. Pressotherapy is conveyed by PC controlled pressure frameworks that generate loads of air situated around the appendages. The chambers inflate sequentially to help push fluid towards the lymphatics and increase draining. This also improves the venous flow around the body. The result of this sequential massage is to assist clear fluid like edema and reduce swelling. Pressotherapy is an excellent treatment on its own but can also be combined with other treatments to increase its lipo-laser and acoustic wave therapy.

Pressotherapy is a treatment that is calibrated and constant weighted rubbing or massage that advances the physiological seepage of interstitial liquid and circulation of blood. The gadget blows up specific pneumatic structures (bladders) that having a flawless anatomical correspondence, wrap appendages and abdomen. The bladders are fuelled by an electronic compressor keeping in mind the end goal to make a peristaltic wave that moves in the distal-proximal bearing in the flow of the fluid stream.

The circulatory framework is an arrangement of vessels that contains and moves some body Fluids i.e. from the blood in blood circulatory framework and the lymph in a lymphatic framework. The bladders comprise of parallel fragments that are deflated and inflated in a successive way guaranteeing a unidirectional stream, without interference or stagnation. The groupings are composed of cycles of a brief span. The weights connected to each portion, can vary from case to case, be that as it may, it must not surpass the circulatory strain, to keep away from harm to the physiological course. The lymph seepage advances blood course encouraging the expulsion of catabolites and waste from the extracellular condition and guaranteeing the supply of new supplements.

Get a Sample Copy of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-3668

Pressotherapy Systems Market Dynamics:

The key contributor to the growth of global Pressotherapy systems includes increasing number of lipo-laser and acoustic wave therapy owing to sedentary lifestyle and expanding elder population base. Poor dietary habits and fluid intake, increasing obesity levels and rising caseload of metabolic disorders may fuel the rate of market growth. Advancements in Pressotherapy system composition materials leading to minimize patient discomfort and give new favor to the market. Availability of innovative smartphone applications has boosted the growth of the market for Pressotherapy systems management and patient safety, which are useful for both physicians and patients.

Pressotherapy Systems Market: Overview

Global Pressotherapy systems market is consolidated with a several players. HEAT Spa Kur Therapy Development Inc., Unmanned Aircraft Systems, Guangzhou Creatbeauty Technology Co., Ltd., Doris Electronic Technology Co., Ltd are some of the key global players in the market. Chinese players have a major share in the Asia Pacific market owing to increasing number of emerging Pressotherapy systems manufacturers and growing demand for the therapy.

Pressotherapy Systems Market: Regional Outlook

Geographically, Pressotherapy systems market is segmented into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. Developed markets like North America and Europe are expected to witness robust growth due to increasing demand and presence of the main global players in the region. Asia Pacific is projected to register positive growth owing to favorable patient demographics and developing healthcare infrastructure in the region. The lack of healthcare infrastructure and insufficient proper training is expected to impact the Pressotherapy systems market in Africa negatively.

Talk to Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-3668

Pressotherapy Systems Market: Key Players

The key players in the global Pressotherapy systems market include DJO Global, Inc., Bio Matrix, Elettronica Pagani Srl, Devon Medical Products Inc., Novasonix Technology Sl., HEAT Spa Kur Therapy Development Inc., Unmanned Aircraft Systems, Guangzhou Creatbeauty Technology Co., Ltd., Doris Electronic Technology Co., Ltd and many more.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Buy this Report Now: https://www.futuremarketinsights.com/checkout/3668

Pressotherapy Systems Market: Segmentation

Global Pressotherapy systems market has been segmented on the basis of application, end-user, and region.

Based on the application, the global Pressotherapy systems market is segmented into:

  • Veno-lymphatic circulation
  • Cellulite at different stages
  • Adiposity edema
  • Reduction of swelling
  • Tired legs
  • Lymphatic drainage
  • Re-modelling
  • Skin elasticity

Based on the end user, Pressotherapy Systems Market is segmented into the following:

  • Hospitals
  • Specialty Clinics

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Dental Tourism Market is anticipated to be worth US$ 137.0 Bn in 2022

The global dental tourism market is primarily driven by increasing cases of dental defects and an increasing preference for cosmetic dentistry worldwide. Lower treatment price and better service in dental treatment abroad, long waiting times at home for dental treatment can stimulate the growth of the market in the near future. Dentist malpractice is likely to hold back the market during the forecast period.

The global dental tourism market is expected to reach a valuation of US$ 6.7 bn in 2022, with sales growth of a 13.6% CAGR during the forecast period. Rapid adoption of technologically advanced medical devices in emerging economies will drive the growth in the market, with the market size reaching € 24.3 bn by 2032.

Rising costs of health care and dental services in developed countries are forcing consumers to adopt dental tourism. This trend is driven by the lack of insurance coverage for major elective dental surgery procedures in several countries.

Get Sample Report@  https://www.futuremarketinsights.com/reports/sample/rep-gb-14623

In addition, treatment costs in countries such as India, Thailand and China are relatively lower than in the countries of North America and Europe. This reflects an increase in dental tourism from Europe and North America to emerging economies. Obtaining a medical visa for such procedures is comparatively faster and easier, thereby facilitating the flow of patients abroad for treatment.

Promotional strategies such as the launch of online campaigns showcasing cost-effective services from healthcare facilities are contributing to the growth of the market. Providing undivided attention to healthcare and providing affordable accommodation sparks consumer interest in adopting attractive medical-tourism packages, identifying both treatment and recreational choices.

With increasing lifestyle-related diseases and unhealthy dietary intake, the incidence of dental disease is increasing. High prevalence of diseases such as dental caries has led to a spike in dental restoration procedures. Thus, the increasing burden of dental abnormalities is propelling the interest in cosmetic dentistry, creating growth opportunities in the market.

“Increasing adoption of technologically advanced medical devices in emerging economies, along with increasing government-backed investment in the The development of healthcare infrastructure in these countries is expected to drive the market in the coming years,” said an FMI analyst.

Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-14623

Key learning points:

  • On a services basis, revenue in the dental cosmetics segment will grow at a robust CAGR of 18.1% through 2032.
  • In terms of providers, the hospital chain segment is expected to account for 47.2% of the total market share by 2022.
  • India will emerge as a lucrative pocket, accounting for 53.9% of the dental tourism market share in South Asia by 2022.
  • What are some of the core competencies and differentiating competencies of new entrants and established players in the industry that we analyze?
  • What are some of the brand opportunities that are developing at a rapid pace?
  • What are the key competitive forces and elements of the external environment that determine the industry lifecycle stages of most organizations?
  • Why are some competitive strategies more popular than others among leaders in a particular market?
  • What customer-based brand value strategies have companies used in a particular industry or set of related industries in an industry?

Competition landscape

With the advancement in cosmetic dentistry, market players are striving to offer these services at affordable prices to gain a competitive advantage. They also invest in mergers, acquisitions and collaborations to expand their global presence. Other strategies include product and service promotions on social media and online channels, as well as partnerships with hospital chains.

Key Market Segments Covered in Dental Tourism Industry Research

By Tourist Type:

  • Domestic
  • International

By Dental Treatment Services:

  • Cosmetic dentistry services
  • Pediatric dental services
  • Periodontal treatments
  • Orthodontic services
  • Diagnostic and preventative dental services
  • Others

Ask for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-14623

By Traveller Type:

  • Independent Traveller
  • Tour Group
  • Package Traveller

By Age Group:

  • 15-25
  • 26-35
  • 36-45
  • 46-55
  • 66-75

By Booking Channel:

  • Phone Booking
  • Online Booking
  • In-Person Booking

By Consumer Orientation:

  • Men
  • Women
  • Children

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

U.S. Animal Model Market is projected to increase at a high CAGR of 4.1 % (2022-2032)

As per Future Market Insights’ latest industry analysis, the U.S. animal model market was valued at over US$ 921.9 Mn in 2021 and is anticipated to exhibit a CAGR of close to 4.1% over the forecast period (2022-2032).

Animal models are predominantly used to gather information regarding the disease and its prevention, diagnosis, and treatment. They are being used to resolve a wide range of scientific concerns, ranging from basic science to the discovery and evaluation of new vaccines and therapies. Animals are used because of the similarities in biology across most mammals.

Get Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14527

Personalized medicine is also known as precision medicine which utilizes data about a specific patient or an individual’s genes to plan treatment for a disease. Animal models can play important role in the development of new approaches for personalized medicine. Increasing adoption of personalized medicine will drive sales of animal model in the forthcoming years.

Toxicity testing in animals is done to discover potential side effects from an agent’s exposure and to generate dose-response relationships. Animal testing is important for the early detection of the potential risk to humans or as models to study the causes, pathogenesis, progression, and treatment of diseases.

Organizations and legislations such as the Federal Food, Drug, and Cosmetic Act (FFDCA), Environmental Protection Agency (EPA), Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), and Organization for Economic Co-operation and Development (OECD) determine the testing guidelines for toxicity testing on animals.

Some factors such as the high production volume of chemicals testing in the U.S., increasing generation and utilization of novel GM animal strains in toxicity studies, and the development and attempted validation of several animal tests to screen chemicals for endocrine (hormone)-disrupting activity are expected to drive the growth in the market.

For in-depth insights, Download a PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14527

Key Takeaways:

  • Based on species, the mice model segment is expected to hold nearly 62.6% of the total market share 2022, with sales growing at a 5.1% CAGR.
  • In terms of therapeutics, the oncology accounted for more than 32.0% of the total market share in 2021, and the trend is expected to continue over the forecast period.
  • By application, sales in the drug discovery/development segment commanded 65.4% of the total market share in 2021.
  • Based on end user, the academic & research institutes segment accounted 36.6% of the total market share in 2021.

Key Players:

  • Charles River Laboratories
  • The Jackson Laboratory
  • Taconic Biosciences, Inc.
  • Genoway
  • Envigo (Inotiv, Inc.)
  • Marshall BioResources
  • Janvier Labs
  • Applied stem cells
  • Biocytogen
  • Transposagen Biopharmaceuticals, Inc. (Hera Bio Labs)
  • Cyagen
  • Ingenious targeting labs
  • Crown Bioscience Inc. (JSR Corporation).
  • Harbour Biomed
  • Sinclair Bio Resources
  • Alpha Genesis Inc.
  • Creative Animodel
  • DaVinci Biomedical Research Products, Inc

For in-depth competitive analysis, Buy Now @ https://www.futuremarketinsights.com/checkout/14527

Market Competition

Key players operating in the U.S. animal model market are expanding their business through partnerships and acquisitions with other companies to improve their global footprint. Following are a few examples of acquisitions:

  • In October 2021, The Jackson Laboratory completed the acquisition of Charles River Laboratories Japan’s Research Models & Services (RMS), which allows advancement in the company’s scientific improvements in basic research and drug discovery.
  • In November 2021, Inotiv, Inc., which is a leading contract research organization (CRO) completed its acquisition of Envigo RMS Holding Corp. to expand its R&D sector.
  • In February 2021, Biocytogen completed the acquisition of a third Beacon Optofluidic system. This acquisition expanded Biocytogen’s service platform in the Boston area.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the animal model market in its latest study, presenting a historical demand assessment of 2017–2021 and projections for 2022– 2032.

The research study is based on the species – (rats, mice, pigs, rabbits, monkeys, dogs, cats, other species), therapeutics- (metabolic diseases, cardiovascular diseases, neurological diseases, and oncology), application (drug discovery/development and basic & applied research) end-user (academic & research institutes, pharmaceutical companies, biotechnology companies, and CROs) and across seven key regions of the world.

Future Market Insights’ Expertise in Life Sciences and Transformational Health

Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Microscope Digital Cameras Market to reach a value of around US$ 1.2 Bn by the end of 2027

Valuable insights on the global scenario of microscope digital cameras have been presented systematically in a recently carried out research on microscope digital cameras market by Future market Insights in its new publication titled “Microscope Digital Cameras: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)”. This research focusses on key players, trends, growth drivers, opportunities, developments and restraints across several key geographies of North America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Latin America, Japan and Middle East and Africa (MEA). On the basis of a structured research process and taking into consideration the past and present scenario, forecasts are provided in the research report from the period 2017 to 2027, a ten year forecast model, across each and every segment of the market.

Global Microscope Digital Cameras Market: Competition Analysis

The global microscope digital cameras market has profiled key players such as Danaher Corporation, Nikon Corporation, Roper Technologies, Inc., Carl Zeiss AG, Olympus Corporation, Hamamatsu Photonics K.K, Basler AG, Guangzhou Micro-shot Technology Co., Ltd., BMS microscopes bv., and Euromex Microscopen bv.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3523

Global Microscope Digital Cameras Market: Forecast Highlights

According to the insightful market survey on microscope digital cameras, the global microscope digital cameras market is anticipated to grow at a high pace to register a robust 9.2% CAGR during the assessment period. During the 2017-2027 period, the global market is estimated to reach a market evaluation of about US$ 1.2 Bn by the end of 2027.

Global Microscope Digital Cameras Market: Segmental Insights

Global microscope digital cameras market is segmented by product type (biological microscope cameras, industrial microscope cameras), by sensor type (CMOS, CCD), by mount type (C mount, eyepiece mount/ocular mount), by end user (hospitals, research laboratories, pharmaceutical and biotechnology industries, clinics) and by region.

  • North America region shows high lucrativeness and is expected to dominate the global microscope digital cameras market during the forecast period with respect to high market valuation. This region is estimated to grow at a stellar growth rate to reach a valuation of about US$ 353.3 Mn by 2027 end. Japan region is expected to grow at the highest rate, a shade higher than North America to register a 10.3% CAGR throughout the forecast period
  • Biological microscope cameras segment by product type, is projected to register a higher CAGR of 9.3% during the forecast period and is more likely to lead the global market by product type in terms of high market value
  • By mount type, C mount segment shows high potential as it grows at a comparatively high rate to reach a 9.4% CAGR and is likely to show dominance over eyepiece mount/ ocular mount segment. The C mount segment shows a market value almost seven times that of the eyepiece mount/ ocular mount segment
  • The CCD segment by sensor type is expected to lead the market with a high value share. The CMOS segment shows high growth rate to register a stellar CAGR of 11.3% throughout the assessment period
  • By end user, research laboratories (clinical and non-clinical) segment dominates the global market with a valuation of about US$ 645.7 Mn in 2027, growing at a robust growth rate. With respect to growth rate, the pharmaceutical and biotechnology industries segment is projected to register the highest CAGR of 9.7% during the period of forecast 2017-2027

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3523

Global Microscope Digital Cameras Market: Dynamics

Various factors favour the growth of the global microscope digital cameras market and the impact of these factors changes from region to region. Diverse application of microscope imaging technology, rising preference for CMOS and CCD, increasing penetration of international players through mergers, growing partnerships for direct distribution, higher spending on academic research along with focus on digital pathology, emergence of digitalization in the life science research, rising demand for microscopy cameras in scientific applications, new product innovations and launches, advancements in microscope digital cameras and rising laboratory automation are supporting the growth of the global microscope digital cameras market. However, factors such as premium pricing limiting market penetration ability, limited manufacturing facilities for microscope cameras, high equipment cost and entry barriers for small players to enter the consolidated market are posing growth restraints to the growth of the global microscope digital cameras market.

Market Taxonomy By Product Type

  • Biological Microscope cameras
  • Industrial Microscope Cameras

By Sensor Type

  • CMOS
  • CCD

By Mount Type

  • C Mount
  • Eyepiece Mount/Ocular Mount

By End User

  • Hospitals
  • Research laboratories
  • Pharmaceutical and Biotechnology Industries
  • Clinics

By Region

  • North America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Latin America
  • MEA

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Respiratory Devices Market Key Players : Massimo Corporation, Teleflex Incorporated, Fisher & Paykel Healthcare Limited

Increasing prevalence of sleep disorders, especially in the U.S. and other European countries, creates lucrative growth opportunities for the sleep testing respiratory devices market. According to the National Healthy Sleep Awareness Project, around 25 million adults in the U.S. were suffering from sleep apnea.  Continuous focus on the market introduction of technologically advanced respiratory devices such as nebulizers, pulse oximeters and spirometers is expected to drive the respiratory devices market growth during the forecast period.

Rising prevalence of chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea has been increasing the demand for respiratory devices. Future Market Insights (FMI) in a new study has forecast the market to continue exhibiting high demand through 2031. While 2020 has proven exceptionally crucial to the market, growth will remain positive 2021 onwards, despite declining a little in comparison to remarkable sales recorded in 2020 amid COVID-19 outbreak.

Growing preference for smart or wearable respiratory devices over general respiratory devices in developed countries also creates a significant opportunity for global market players operating in the respiratory devices market. Adoption of portable devices for neonatal and adults suffering respiratory diseases is growing respiratory devices demand. For instance, Patients suffering from chronic respiratory diseases require continuous oxygen supply. A portable oxygen concentrator has several other benefits such as lightweight, small shape and easy to carry, which makes it the best choice of device.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-794

Hospitals are likely to remain chief end users of respiratory devices. They have been relentlessly offering patient care amid COVID-19 outbreak. Even as numbers of COVID-19 patients soared, healthcare centers around the world pushed through challenges to offer required care. Hospitals therefore accounted for a little above 40% of respiratory devices sold in 2020. By 2031, the number of respiratory devices sold in hospitals is expected to rise further.

Key Takeaways of Respiratory Devices Market Study

  • Respiratory devices market will exhibit impressive growth through 2031. The market is forecast to exhibit 9.3% CAGR in 2021
  • S. will remain the most lucrative market, accounting for almost 87% of respiratory devices sold in North America
  • UK will exhibit impressive Y-o-Y growth at 10.5% in 2021
  • Germany and France will continue exhibiting high demand for respiratory devices
  • China and Korea will remain bright spots in East Asia market, however, Japan will remain dominant through the forecast period

Partnerships to Develop New Products – Imperative Strategy for Market Players

Leading manufacturers of the respiratory inhaler are focusing on strategic partnerships with software and digital companies to serve the selected population. Besides, such collaborations also help manufacturers improve their distribution channels as well as to launch their products. For instance, In June 2020, Medtronic plc entered into a partnership with Foxconn Industrial Internet to begin manufacturing Medtronic’s Puritan Bennett 560 (PB560) ventilators in the United States.

Similarly, Smith’s Medical has signed a distribution partnership with Medline Industries for distribution of the Portex acapella, a vibratory PEP therapy device to focus on the non-acute and home care channels in 2019.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-794

Key Segments

Product

  • Respiratory Consumables
    • Respiratory Mask
    • Nasal Cannulas
    • Oxygen Tubing Sets
    • Breathing Filters
  • Nebulizers
    • Compressed Jet Nebulizers
    • Ultrasonic Nebulizers
  • Oxygen Concentrators
    • Home Oxygen Concentrators
    • Portable Oxygen
    • Concentrators`
  • Positive Airway Pressure (PAP) Devices
  • Polysomnography Devices
    • Ambulatory PSG Devices
    • Clinical PSG Devices
  • Pulse Oximeters
  • Mechanical Ventilators
  • Spirometers

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-794

End Users

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Long Term Care Centers
  • Others

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • The Middle East and Africa (MEA)
  • Oceania

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Manometry Systems Market to reaching a valuation of US$ 279.6 Million by 2031

[250 Pages Report] Sales of global manometry systems are expected to reach US$ 157.3 Mn in 2020. As per Future Market Insights, revenues for manometry systems are expected to reach US$ 279.6 Mn, expanding at a 5.4% CAGR over the forecast period (2021-2031).

Rise in number of people aged 65 years and older is expected to be the major factor boosting the growth of the manometry system market. In 2018, According to the U.S. Census Board people older than 65 years represent around 13% of the total population; this percentage is expected to reach 20% by 2031.

Rising cases of constipation, fecal incontinence, anorectal pain, pelvic floor dyssynergia and hirschsprung’s among older population is increasing the adoption of manometry systems. Demand for these systems helps evaluate patients and provides many useful data regarding anorectal function and indicates the prognosis of treatment, particularly in the management of sphincter injuries.

Get Sample Report@  https://www.futuremarketinsights.com/reports/sample/rep-gb-14110

Rising demand for non-invasive equipment is driving the demand for manometry system. These systems are non-invasive diagnostic procedure that can detect pressures and sensation in the anus and rectum. With this, they indicate whether the patient’s pelvic function is normal without incision into the body or removal of tissue and has low risks, and complications.

Further, rising government initiatives and funding supporting the development of product is boosting the demand for manometry system market.  Initiatives undertaken by government to enable and boost the ecosystem for the indigenous medical device industry is also stimulating market growth.

Base Year Value (2020A) US$ 157.3 Mn
Projected year (2031) Market Value US$ 279.6 Mn
CAGR% (2021-2031) 5.4% CAGR

“As demand for manometry systems is rising due to high prevalence of gastrointestinal diseases, key players are engaging in product development that is technologically advanced for faster approvals. This is expected to give the key players a competitive edge in the industry, generating revenues,” says the FMI Analyst

Key Takeaways from Manometry System Market Study

  • By product, system sheath & catheters is expected to account for the largest share of 55.0% in 2021.
  • In terms of portability, stand-alone system will hold for the largest share of 55.4% in 2021 on the back of its enhanced sensitivity to provide accurate diagnosis of condition
  • By end user, hospitals accounted for the largest share of 37.9% in 2021 owing to the rising demand for hospital stay that is short-term and increasing number of gastrointestinal processes.
  • North America is expected to hold largest share of 38.9% in 2021 with the U.S. leading the market during the forecast period.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-14110

Who is Winning?

Some of the leading manufacturers of manometry system market are focusing on product launch collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

Several joint ventures, agreements, and loan licensing procedures have influenced the market. The government of developing economies has taken several reforms to develop the market by regulating it to bring out more transparency and by allowing foreign investments in the industry.

New Product launches & approvals have emerged as key growth strategy adopted by the leading players in the manometry system market. Followed by this, acquisition was the second most key strategy adopted by the industry players. By adopting these strategies, it helped the company to expand their regional presence as well as product offerings.

For instance,

  • In October 2021, “UROTECH GmbH subsidiary of Medi-Globe Group’s provided detailed information on a new clinical study for using the Magnetic Black-Star® (MBS) in paediatric urology. The MBS was an innovative product of the UROTECH GmbH, which is used in stent placement as well as stent removal of children by without performing the surgeries using the stent’ magnetic tip.”
  • In May 2020, RMS Medical Devices, proudly announced it’s the acquisition of QUICKORE products for BENELUX. With this new acquisition, RMS Medical Devices adds another premium technology to its Radiology portfolio.
  • In October 2020, LABORIE Medical Technologies enters into strategic partnership with Urotronic to support regulatory approval of Optilume™, a drug-coated balloon (DCB) technology for use in urethral strictures and benign prostatic hyperplasia (BPH).
  • In August 2021, Medtronic Announced the FDA Approval of Next-Gen TAVR System for the treatment of symptomatic severe aortic stenosis. Next-Gen TAVR System is a self-expanding transcatheter aortic valve replacement, which is designed to enhance ease-of-use and predictable valve deployment throughout the procedure.

The key market players covered by FMI include EB Neuro S.p.A, MEDSPIRA, Medtronic, Medica S.p.A., RMS Medical Devices, MARQUAT Génie Biomédical, Diversatek Inc., Dentsleeve International Ltd., LABORIE, Prometheus Group, Smart Medical Group, Synectics Medical Limited, Medovations Inc., Sierra Scientific, and Urotech Gmbh.

Manometry System by Category

Product:

  • Anorectal Manometry System
  • Anorectal Manometry System Software
  • Anorectal Manometry System Sheath & Catheters

Portability:

  • Stand Alone System
  • Portable System

End User:

  • Hospitals
  • Diagnostic Centers
  • Speciality Clinics
  • Academic Research Institutes

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Home Infusion Therapy Devices Market is expected to total US$ 3.8 Billion by the end of 2031

According to a recent study by Future Market Insights (FMI), sales of home infusion therapy devices are expected to top US$ 2.0 Bn in 2021, growing at a CAGR of over 6.5% during the forecast period (2021-2031).

Home infusion therapy devices are used for the intravenous administration of medicines. It is commonly prescribed for patients with serious infections and specialized diseases when orally administered medicines are not or comparatively less effective.

Application of home infusion therapy devices is increasing with the rising number of surgeries conducted across the globe. Post-surgery pain management at home can be done with the help of home infusion therapy devices.

Besides this, rising healthcare expenditure and growing awareness regarding the risk and infection amidst the outbreak of COVID-19 is driving the demand of home infusion therapy devices.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13974

Key Takeaways from Home Infusion Therapy Devices Market Study

  • By product type, infusion system accessories will hold around 45% of value share globally.
  • Based on the application, antibiotic administration is leading with over 34% of the market share.
  • Home care settings sales will dominate the home infusion therapy devices, with a market share of 65% during the forecast period.
  • By region, the U.S. will dominate the global home infusion therapy devices market with a value share of around 37% during the forecast period.
  • Followed by North America, Europe will be the second-largest leading region, with a value share of 93.2% during the forecast period.
  • India is the dominant country in term of revenue for South Asia Home infusion therapy devices market, accounting for nearly 48% of market share in 2021.
  • China holds leading position in East Asia and is expected to account for nearly 52% of market share.

“Growing prevalence of chronic diseases such as diabetes and cancer in the midst of COVID-19 pandemic and high risk of infection across hospitals encouraged key players to invest in new product launches. This is expected to enable growth in the market in the coming years” says a FMI Analyst.

Who is Winning?

Key players are focusing on new product launches and approvals. Other growth strategies adopted by leading players include, agreements, and collaborations among key manufacturers. By focusing on these strategies, key players are expanding their geographic presence and strengthening their existing product portfolio.

For instance,

  • In June 2019, Baxter International Inc. announced that Myxredlin that is the first and only ready-to-use insulin for IV infusion get the US FDA approval.
  • In Jan 2019, Fresenius Kabi AG launched two colourful bags via white spiral cables to supply the nutrient solution for parenteral nutrition.
  • In April 2017, B. Braun Melsungen AG announced the launch of home infusion therapy App named Easypump® for healthcare professionals and patients.

The key market players profiled by FMI include Becton, Diciknson & Company, B.Braun Melsungen AG, Baxter International, Fresenius Kabi, Terumo Corporation, ICU Medical, Nipro Corporation, Smiths Medical, Micrel Medical Devices SA, Moog Inc., JMS Co.Ltd., Intera Oncology, and Others Top-up.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13974

Home Infusion Therapy Devices Market by Category By Product Type:

  • Disposable Elastomeric Pumps
  • Insulin Pumps
  • PCA Pumps
  • Electronic Ambulatory Pumps
  • Infusion System Accessories

By Applications:

  • Enteral Nutrition
  • Parenteral Nutrition
  • Chemotherapy
  • Antibiotic Administration
  • Others

By End User:

  • Home Care Settings
  • Long Term Care Centers

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Biological and Chemical Indicators Market to grow at CAGR of 7.2% through 2030 | FMI

[269 Pages] According to Future Market Insights (FMI) the worldwide yearly tracker, vendor revenue in global biological & chemical indicators market will grow 9.1% year over year to 396.8 Mn in 2020. Global shipments will rise 9.7% year over year to 830.7 Mn units in 2020.

Irrespective of the COVID-19 pandemic, demand for biological and chemical indicators has been surging tremendously as sterilization has always been at forefront of duties of healthcare facilities.

However, the role will be put to test in near future as epidemiological numbers continue to rise amidst the public health crisis. As such, FMI foresees healthy growth trail for global biological and chemical indicators market over forecast period 2020-2030.

Get Sample Report@  https://www.futuremarketinsights.com/reports/sample/rep-gb-12544

“After oral administration, parenteral dosage is the most prevalent way of providing drugs to patients. At present, about 95% of recently approved biopharmaceuticals are parenteral dosage form. This rise in commercialization and manufacturing of parenteral drugs will propel the adoption of biological and chemical indicators in biopharmaceuticals companies,” says analyst at FMI.

COVID-19 Impact on Biological & Chemical Indicators Market

The COVID-19 pandemic will trigger the demand for biological and chemical indicators for short-term to validate sterilization process in hospitals, ambulatory surgical centers (ASC), and clinics.

The pandemic has put pressure on frontline healthcare workers to follow strict cleaning and disinfection protocols as they are specifically at risk of contracting and spreading the infection. This has triggered the need for sterilization measures enacted during surgical procedures due to concerns of COVID-19 transmission among hospitalized patients.

The World Health Organization (WHO) has advised personal protective equipment (PPE) industry and governments to ramp up their manufacturing by 40% to cater to surging worldwide demand. This high pool of medical equipment with need for proper sterilization will bode well for biological & chemical indicators market in immediate future.

Biological & Chemical Indicators Market – Competitive Intelligence

The global biological & chemical indicators market is highly consolidated with top 5 players – 3M Company, Steris Plc., and Thermo Fisher – collectively accounting for around 4/5 of overall market revenue. In order to sustain competition due to increasing number of new and small companies, leading players are focusing on mergers and acquisitions (M&A). For instance,

  • Thermo Fisher Scientific Inc. has acquired QIAGEN N.V. – leading worldwide provider of sample preparation and molecular diagnostics technologies. This acquisition will enable the company to leverage its industry-leading capabilities and R&D expertise to speed up innovation and deal with emerging healthcare needs.
  • McKesson Medical-Surgical Inc. has entered into an agreement with Walgreens Boots Alliance to combine their respective pharmaceutical wholesale businesses in Germany.
  • Cantel Medical has taken over Hu-Friedy, which manufactures dental instruments and reprocessing equipment.

Want to Know More About Biological & Chemical Indicators Market?

Future Market Insights, in its new study, provides compelling insights about the biological & chemical indicators market that encloses industry analysis for 2015 – 2019 and opportunity assessment for 2020 – 2030. The report offers unbiased assessment on biological & chemical indicators market through five different categories – sterilization type, indicator class, packaging form, end user, and region. The global biological & chemical indicators market research study delivers insights of pricing by different life cycle analysis, product life cycle, major market trends and technologies that are being utilized in the development of biological & chemical indicators and product adoption in various end users.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-12544

Biological & Chemical Indicators Market Segmentation Sterilization Type

  • Thermal Sterilization
    • Steam Heat
    • Dry Heat
  • Chemical Sterilization
    • Ethylene Oxide
    • Hydrogen Peroxide
    • Formaldehyde
  • Radiation Sterilization

Indicator Class

  • Biological Indicators
    • Bacillus atrophaeus (BA) Spores
    • Geobacillus stearothermophilus (GS) Spores
    • Others
  • Chemical Indicators
    • Class 1 (Process)
    • Class 4 (Multi-Variable)
    • Class 2 (Specific-Use)
    • Class 3 (Single-Variable)
    • Class 5 (Integrating)
    • Class 6 (Cycle Verification)
  • Enzyme Indicators

Packaging Form

  • Self-Contained BI
  • Spore Suspension BI
  • Strip and Disc BI
  • Strip and Disc CI
  • Others

End User

  • Biopharma Industry
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Labs
  • Research Labs

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12544

Regional Outlook

  • North America (US, and Canada)
  • Latin America (Brazil, and Mexico)
  • Europe (Germany, UK, Russia, France, and Italy)
  • South Asia (India, Indonesia, Thailand, Australia and New Zealand)
  • East Asia (China, Japan, and South Korea)
  • Oceania (Australia and New Zealand)
  • Middle East & Africa (MEA) (Turkey, GCC Countries, and South Africa)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Acetaminophen API Market is anticipated to Boost owing to Rise in Usage of Drugs for Pain-relieving Effects

Acetaminophen API Market Dynamics:

The easy availability of this drug is boosting the growth of the Acetaminophen API market.  Meanwhile increasing usage of drugs for pain-relieving effects is propelling the growth of the Acetaminophen API market. Moreover, rising incidences of accidents, surgeries are further boosting the Acetaminophen API market.

Moreover, people addiction to using these drugs for rapid pain relief also fueling the growth of the Acetaminophen API market. Additionally, environmental conditions, lifestyle changes & dietary habits modifications are responsible for a variety of disorders which increases the consumption of these drugs. However, the excessive dosage can cause toxicity which can lead to serious complications such as liver diseases, fertility issues, carcinogenesis & mutagenesis which can hamper the growth of the Acetaminophen API market.

Get Sample Free Sample of this Premium Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-12465

Acetaminophen API Market: Overview

The usage of acetaminophen grade is higher due to its wide utilisation in the drug development process. While it is widely used in the pharmaceutical industry as a pain killer which offers a lucrative opportunity for the growth of the Acetaminophen API market in the forecasted period. Aside from this, the acetaminophen drug is combined with various drug and available in various forms, but it is mostly available in the form of extended-release tablets for showing analgesics effects. But heavy usage of this drug can cause serious adverse effects & can build toxicity which leads to other diseases.

Acetaminophen API Market: Regional Wise Outlook

Geographically, the Acetaminophen API market is divided into seven regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, China, Japan & the Middle East and Africa.  Asia-Pacific is expected to dominate the global acetaminophen API market followed by North- America & Europe.

Asia-Pacific is dominating the global acetaminophen API market due to higher population rate which led to increased accidental cases, surgeries & various disorders, thus the demand for the drugs is increasing in this region which is boosting the Acetaminophen API regional market. While the increasing healthcare conditions & awareness amongst the people is further fuelling the Acetaminophen API market. Rapid development & Advancements along with the changing environmental conditions is going to offer a lucrative opportunity for the growth of acetaminophen API market in North America during the forecasted period.

Talk to Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-12465

Acetaminophen API Market: Key Market Participants

The key participants operating in the global acetaminophen API market identified across the value chain are

  • BOC Sciences
  • Tianjin Bofa Acetaminophen
  • Mallinckrodt plc
  •  Kemcolour International
  • Changshu Huagang Acetaminophen
  • Haohua Industry
  • Kangle Acetaminophen
  • Angene International Limited
  • Anhui BBCA Acetaminophen
  • Granules India
  • Hebei Jiheng Acetaminophen
  • Glosel India Impex Pvt Ltd. from India
  •  Flare S.A. from Switzerland
  • Silverline chemicals ltd from India
  • Emkay Pharma Pvt Ltd from India
  • Atabay K.S.V.T. from Turkey
  • Anqiu Lu’An from China
  • United Pharma Industries Co Ltd from China
  • Farmson from India
  • Liaoyuan City Baikang from China

The players working in the worldwide acetaminophen API market are concentrating on the drug discovery i.e. by combining the API with various other extracts for the development of new therapeutic medication which would be helpful in prevention & cure of various disorders. Currently, the company are focusing at the collaborations, mergers & acquisitions with other companies.

The report covers exhaust analysis on

  • Acetaminophen API Market Segments
  • Acetaminophen API Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Buy this Report Now: https://www.futuremarketinsights.com/checkout/12465

Acetaminophen API Market Segmentation

The global Acetaminophen API market has been segmented based on product form, type, application, end-user and geography.

Type

  • Veterinary Drug Grade
  • Acetaminophen Grade

End-user

  • Pharmaceuticals Industry
  • Research labs
  • Educational institutes
  • Others

Product Form

  • Tablets (film-coated, extended-release)
  • Oral Solution
  • Suppository
  • Injection
  • Others

Indications

  • Antipyretic
  • Analgesics
  • Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs